The day's trading range so far on BSE was between Rs 132.50 and Rs 143.35.

The stock advanced steadily from the close of Rs 116.60 on 20 October 2005 to close at Rs 131.85 yesterday.

Wanbury moved strong today after it, along with its associate companies, acquired a 51% stake in Doctors Organic Chemicals Ltd (DOCL). DOCL has a large USFDA approved facility and sells Active Pharmaceutical Ingredients (APIs) in regulated markets like the US and Europe. DOCL also undertakes contract manufacturing for large pharma MNCs.

Wanbury is the merged entity of Pearl Organics and Wander Pvt. Ltd, an erstwhile subsidiary of Sandoz. With this merger, the consolidated entity - Wanbury - has emerged as an integrated pharmaceutical company offering bulk drugs and formulations under one roof.

During the quarter ended 30 September 2005, the company raised Rs 440.2 crore through the issue of 10.87 lakh Global Depository Receipts (GDR) at an offer price of US $9.20 per GDR. Each GDR represents three fully paid-up equity shares of Rs 10 each issued at Rs 135 per equity share.

For the quarter ended September 2005, the company reported a 33.62% rise in net profit to Rs 3.06 crore (Rs 2.29 crore). Net sales increased 32.59% to Rs 24.53 crore (Rs 18.50 crore).